Disodium Pamidronate Injection

We offer Disodium Pamidronate Injection that could be used as a bone resorption inhibitor and could be prescribed to patients with Pagets disease. This injection should not be administered to patients with hypersensitivity to pamidronate or any other biphosphonates. The standard hypercalcemia-related metabolic parameters like the serum levels of phosphate, calcium, magnesium and potassium should be monitored in patients once the injection is administered.

We are offering di sodium pamidronate injection it is a bone resorption inhibitor :

• Composition : 15mg, 30mg, 60mg, 90mg
• Indications : Hypercalcaemia of malignancy, paget's disease, osteolytic bone metastasis of breast cancer, and osteolytic lesions of multiple myeloma.
• Contraindications : Patients with clinically significant hypersensitivity to pamidronate or other biphosphonates.
• Safety Profile : Standard hypercalcemia related metabolic parameters such as serum levels of calcium, phosphate, magnesium and potassium should be carefully monitored.